0 results found with selected filters. Please refine the filters. Redirecting to initial search..
Table "column sort" updates the order of the bars in the chart.
downloaded on: 2025/12/13 03:53:20
| Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Average Type |
Value |
Units |
SEM |
SD |
Method |
Method Site |
Method Duration |
Post Insult Type |
Post Insult Time Value |
Clinical Measurement Notes |
Record ID |
Study ID |
| ACI/SegHsd |
post-insult time to mammary tumor formation |
17 beta-estradiol (27.5 mg) (between 99 and 197 days) |
Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 |
mammary gland integrity trait |
female |
160.0 days-260.0 days |
21 |
serial mean |
145.0 |
d |
|
|
manual palpation method |
mammary gland |
0.0 |
|
|
|
66104 |
76 |
| ACI/SegHsd |
post-insult time to mammary tumor formation |
17 beta-estradiol (27.5 mg) (between 99 and 197 days) |
Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 |
mammary gland integrity trait |
female |
160.0 days-260.0 days |
21 |
median |
143.0 |
d |
|
|
manual palpation method |
mammary gland |
0.0 |
|
|
|
66111 |
76 |
| ACI/SegHsd |
post-insult time to mammary tumor formation |
17 beta-estradiol (27.5 mg) (for 196 days) |
Kurz SG, et al., Endocrinology. 2008 Apr 17 |
mammary gland integrity trait |
female |
days-259.0 days |
21 |
|
145.0 |
d |
|
|
manual palpation method |
|
0 |
|
|
median |
11375 |
75 |
| ACI/SegHsd |
post-insult time to mammary tumor formation |
17 beta-estradiol (27.5 mg) (between 147 and 195 days) |
Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 |
mammary gland integrity trait |
female |
206.0 days-264.0 days |
31 |
|
141.0 |
d |
4.85 |
27.0 |
manual palpation method |
|
|
|
|
mean |
11748 |
144 |
| ACI/SegHsd |
post-insult time to mammary tumor formation |
17 beta-estradiol (27.5 mg) (between 193 and 199 days) |
Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 |
mammary gland integrity trait |
female |
143.0 days-259.0 days |
22 |
median |
133.0 |
d |
|
|
manual palpation method |
|
0 |
crystalline implant |
|
|
65763 |
81 |
| ACI/SegHsd |
post-insult time to mammary tumor formation |
17 beta-estradiol (27.5 mg) (between 193 and 199 days) |
Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 |
mammary gland integrity trait |
female |
143.0 days-259.0 days |
22 |
|
136.0 |
d |
6.0 |
28.14 |
manual palpation method |
|
0.0 |
crystalline implant |
|
|
11383 |
81 |
| ACI/SegHsd |
post-insult time to mammary tumor formation |
17 beta-estradiol (27.5 mg) (between 147 and 195 days) |
Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 |
mammary gland integrity trait |
female |
206.0 days-264.0 days |
31 |
median |
140.0 |
d |
|
|
manual palpation method |
|
|
|
|
median |
11750 |
144 |
|